It will be a pleasure if you let us know how we can help you and be useful to you in clinical trials. We will be more than happy to be selected as one of your investigative site. You can contact us at info@guardianresearchcenter.com.
.Have a additional questions? Contact us today at 813-512-7479.
You are being asked to take part in this study because you have a condition called non-alcoholic steato hepatitis (NASH); a disease described as inflammation and fat accumulation in the liver. The Study Drug, EDP-35 is being developed as a potential treatment for NASH. The purpose of this study is to compare the effects of cwith placebo in order to see which study treatment is better or is safer than having no treatment. This Study may or may not provide benefit. However, some doctors have noticed and improvement in components for NASH for example, fat content of the liver and other blood markers being associated with NASH in subjects taking EDP-305 in other research studies.lick to edit text. What do visitors to your website need to know about you and your business?
